Bayer says its experimental blood thinner cuts risk and severity of repeat strokes Bayer said on Wednesday new analyses ‌showed its experimental blood thinner asundexian reduced the incidence and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results